Non-small Cell Lung Cancer Market is Projected to Boost by 2032, Predicts DelveInsight | Key Companies Working in Space - AstraZeneca, BMS, AbbVie, Roche, Merck, Novartis, Pfizer, Takeda, Eli Lilly, Immutep, Sanofi, GlaxoSmithKline
27 juil. 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, July 27, 2023 (GLOBE NEWSWIRE) -- Non-small Cell Lung Cancer Market is Projected to Boost by 2032, Predicts DelveInsight | Key Companies Working in Space - AstraZeneca, BMS, AbbVie,...
Global NSCLC Market Size to grow USD 38.8 Billion by 2030 | CAGR of 10.4%: Spherical Insights
09 mars 2023 06h30 HE
|
SPHERICAL INSIGHTS LLP
New York, United States, March 09, 2023 (GLOBE NEWSWIRE) -- Global NSCLC Market worth $38.1 Billion by 2030 According to a research report published by Spherical Insights &...
Merck & Co., Roche, and BMS Among Leading Players in the Non-Small Cell Lung Cancer Drugs Market | GlobalData Plc
20 juil. 2022 09h45 HE
|
GlobalData Plc
LONDON, July 20, 2022 (GLOBE NEWSWIRE) -- The “Non-Small Cell Lung Cancer (NSCLC) – Global Drug Forecast and Market Analysis to 2029” report offered by GlobalData provides an overview of NSCLC...